tiprankstipranks
Advertisement
Advertisement
4D Molecular Therapeutics Secures $200 Million Loan Facility
PremiumCompany Announcements4D Molecular Therapeutics Secures $200 Million Loan Facility
1M ago
4D Molecular completes enrollment in 4FRONT-2 trial
Premium
The Fly
4D Molecular completes enrollment in 4FRONT-2 trial
1M ago
4D Molecular Therapeutics Stockholders Back Directors and Governance
Premium
Company Announcements
4D Molecular Therapeutics Stockholders Back Directors and Governance
1M ago
4D Molecular reports Q1 EPS ($1.01), consensus ($1.00)
PremiumThe Fly4D Molecular reports Q1 EPS ($1.01), consensus ($1.00)
3M ago
4D Molecular price target lowered to $23 from $45 at Evercore ISI
Premium
The Fly
4D Molecular price target lowered to $23 from $45 at Evercore ISI
4M ago
4D Molecular Therapeutics Consolidates Financial Leadership Under New Role
Premium
Company Announcements
4D Molecular Therapeutics Consolidates Financial Leadership Under New Role
4M ago
4D Molecular assumed with an Overweight at Barclays
PremiumThe Fly4D Molecular assumed with an Overweight at Barclays
6M ago
4D Molecular Therapeutics Restructures Equity via Warrant Exchange
Premium
Company Announcements
4D Molecular Therapeutics Restructures Equity via Warrant Exchange
6M ago
4D Molecular announces employment inducement grants
Premium
The Fly
4D Molecular announces employment inducement grants
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100